Health care is already Alberta's. Hospitals, physicians, emergency medical services, continuing care, public drug programmes and the entire health workforce are provincial today and stay provincial on Day 1. Nothing in this domain buys a hospital or hires a nurse, and the figures here are an administrative continuity floor rather than a health system budget.
What is federal is a thin layer above the system: regulation of medicines and medical devices, national public health surveillance and reference laboratory capacity, the health data infrastructure that shows whether the system is working, and the health of populations Ottawa covers directly. On medicines Alberta recognises rather than replicates — it legislates recognition of approvals already made by designated foreign regulators and deems existing Canadian approvals effective, so that products on the market stay lawful and pharmacies keep dispensing. The Alberta authority does gatekeeping, surveillance, shortage management and emergency decisions, not primary product review.
The largest number in health does not appear in this domain and should not. The Canada Health Transfer to Alberta is about C$7.0 billion a year, plus health bilaterals. That is revenue that stops, not a cost that starts, and it is accounted for on the revenue side of this budget and in the sovereign liquidity plan sized to bridge it.
C$ millions, fiscal 2026-27 price base. A one-time cost, a recurring cost and a payment to a member of the public are different things and are never added together.
How the figure is built
C$75.0M a year of added running cost and C$273.7M one-time, of which C$114.0M is capital, plus C$13.8M met by fees on the manufacturers and wholesalers regulated. Health care is already Alberta's: hospitals, physicians, emergency medical services, continuing care, public drug programmes and the entire health workforce are provincial today and stay provincial. Nothing here buys a hospital or hires a nurse. What is new is the thin federal layer above them - medicines and devices regulation, national public-health surveillance and reference laboratory capacity, the health data rails, and the populations Ottawa covers directly.
The lines
| C$M | ||
|---|---|---|
| Alberta Medicines and Devices Authority | 34.4 | |
| Public health surveillance, response and reference laboratory | 35.8 | Includes reagents and reference testing |
| Health data and indicators | 22.2 | Includes indicator production |
| Supply chain, stockpile and allocation | 21.9 | Includes stockpile rotation |
| Federal-population health continuity | 11.4 | |
| International health and standards interface | 9.1 | |
| FULL COST, a year | 134.8 | |
| Met by regulatory fees | 13.8 | Establishment licences and right-to-sell fees on manufacturers and wholesalers, as the federal regulator charges today |
| Already funded | 46.0 | Provincial laboratory, chief medical officer, surveillance and health analytics capacity. The paper calls its own payroll footprint embedded and non-additive |
| ADDED RUNNING COST, a year | 75.0 | |
| Health data platform and minimum sovereign dataset | 34.0 | Replaces the national data rails |
| Strategic stockpile establishment | 26.0 | The paper is explicit that stockpiles are built before Day 1, not after |
| Regulatory systems | 22.0 | Product registry, establishment licensing, adverse events, recalls |
| Reference laboratory capability uplift | 20.0 | Confirmatory testing now sent to the national laboratory |
| Surveillance and outbreak systems | 12.0 | Reportable disease, laboratory feeds, signals |
| Capital | 114.0 | |
| Legislative programme | 24.0 | The continuity regime and the two new authorities |
| Data migration and records | 20.0 | So visibility does not go dark at the cutover |
| Recognition framework | 18.0 | Designating foreign authorities and deeming existing approvals effective |
| Federal-population continuity arrangements | 16.0 | |
| Programme management and assurance | 16.0 | 24-month stand-up |
| International health engagement | 14.0 | Health regulations compatibility pending accession |
| Contingency at 15% | 35.7 | |
| ONE-TIME TOTAL | 273.7 |
The people
| Posts | C$M | ||
|---|---|---|---|
| Alberta Medicines and Devices Authority | 160 | Gatekeeping, designation, licensing, surveillance, recalls, shortages. Not product review | |
| Public health surveillance, response and reference laboratory | 120 | The sovereign layer above what Alberta already runs | |
| Health data and indicators | 80 | A minimum sovereign dataset, indicators, interoperability, public reporting | |
| Supply chain, stockpile and allocation | 60 | Import corridors, cold chain, central allocation, shortage response | |
| Federal-population health continuity | 45 | Veterans, serving police, federal inmates, protected persons | |
| International health and standards interface | 25 | Health regulations compatibility, pharmacopoeial standards | |
| Permanent posts | 490 | ||
| Recruitment and training | 16 | 490 posts | |
| Complement carried | 490 permanent and 72 temporary, none of them clinical |
Comparators
| Figure | ||
|---|---|---|
| Health Canada, 2026-27 planned | about C$10,979M | The paper's own comment: 'Alberta does not need to mirror those budgets' |
| Public Health Agency of Canada | about C$1,527M national | Stockpile, national laboratory, surveillance and emergency functions |
| Canada Health Transfer to Alberta | about C$7,036M a year |
What these figures assume
- Alberta recognises rather than replicates. Products and compliance decisions made by designated foreign authorities are recognised by regulation, with transitional deeming of approvals already granted by Canada, and the medicines authority does gatekeeping, surveillance, shortage management and emergency decisions rather than full product review. This is the same answer the regulatory domain reached for patents.
- The medicines authority charges the industry it regulates, as the federal regulator does through establishment licence and right-to-sell fees. No other function in the domain has a fee base: surveillance, laboratory capacity and health data are public goods.
- Much of the public health, laboratory and data capacity already exists provincially and is treated as existing funding under the rule that existing funding is identified and only the increment counted. The paper supports this directly, classifying its own identified payroll footprint as embedded and non-additive.
- Capital is not cut hard. A sovereign health dataset, a strategic stockpile and reference laboratory capability are the three things that cannot be improvised after an outbreak starts, and the paper requires the stockpile to be in place before Day 1 rather than after.
Contingency, recognised at C$0
Alberta's public drug programmes buy at prices negotiated collectively for all provinces through the pan-Canadian Pharmaceutical Alliance, under a federal ceiling on patented prices. Leaving Canada leaves both. The product listing agreements that carry the value are confidential rebate arrangements by design, so the exposure cannot be sized from public information by anyone outside them. It lands on a drug programme already inside the provincial budget, so it is an increase in an existing line rather than a new one.
How this connects to other domains
Hospitals, physicians, emergency medical services, continuing care and the health workforce are provincial today and are not costed here. Non-Insured Health Benefits is excluded and sits at Indigenous Relations and Treaty inside the memorandum exposure at nil recognition - and the Alberta-region figure of about C$288.1M published in this paper corroborates the pro-rata band used there. Benefit payment continuity uses the same mechanism as Social Programs and is adopted by reference rather than rebuilt. Health of federal inmates connects to Policing and Public Safety corrections. Medicines and devices recognition arrangements with foreign regulators are negotiated by International Relations.
Sources
- Alberta Transition Plan supporting analysis, Health - Section 6 functional design, Section 6.6 staffing and budgetary considerations, and the federal flows table.
- Health Canada, Public Health Agency of Canada and Canadian Institutes of Health Research 2026-27 planned spending, as cited by the paper.
- Alberta Budget 2026 - Health, and Alberta Precision Laboratories.
